Jeffrey E. Russel

Array ( [id] => 6578820 [patent_doc_number] => 20100047369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'ANTI-TUMOR DRUG, MEDICAMENT, COMPOSITION, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/608507 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9736 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047369.pdf [firstpage_image] =>[orig_patent_app_number] => 12608507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937353 [patent_doc_number] => 20110212892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'AGENT FOR TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 13/126333 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6676 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212892.pdf [firstpage_image] =>[orig_patent_app_number] => 13126333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234833 [patent_doc_number] => 20100266537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'HCV INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/605271 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23312 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266537.pdf [firstpage_image] =>[orig_patent_app_number] => 12605271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6472190 [patent_doc_number] => 20100041072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'PROCESS FOR IDENTIFYING A LIGAND THAT BINDS TO THE NEP BINDING SITE FOR THE SMR1 PENTAPEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/580701 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14806 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041072.pdf [firstpage_image] =>[orig_patent_app_number] => 12580701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561728 [patent_doc_number] => 20110275561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug' [patent_app_type] => utility [patent_app_number] => 13/124196 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13851 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275561.pdf [firstpage_image] =>[orig_patent_app_number] => 13124196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9046806 [patent_doc_number] => 08541359 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => 'Pharmaceutical compositions and methods for peptide treatment' [patent_app_type] => utility [patent_app_number] => 12/562974 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6234 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12562974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063675 [patent_doc_number] => 20110245179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Composition for Prevention or Treatment of Heart Failure' [patent_app_type] => utility [patent_app_number] => 13/119328 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9634 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245179.pdf [firstpage_image] =>[orig_patent_app_number] => 13119328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174215 [patent_doc_number] => 20110177060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'IAP BIR DOMAIN BINDING COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/119900 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16743 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177060.pdf [firstpage_image] =>[orig_patent_app_number] => 13119900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487222 [patent_doc_number] => 20110236309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'ANTAGONISTS OF LIGANDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/063753 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11883 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236309.pdf [firstpage_image] =>[orig_patent_app_number] => 13063753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064864 [patent_doc_number] => 20110201781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'CYSTEINE LABELING SYSTEM AND METHOD OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/998105 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2154 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201781.pdf [firstpage_image] =>[orig_patent_app_number] => 12998105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710168 [patent_doc_number] => 20120003203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Compositions and Methods for Treating S. Pneumoniae Infection' [patent_app_type] => utility [patent_app_number] => 13/063318 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21752 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13063318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656413 [patent_doc_number] => 20110305682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Compositions and Methods for Treating S. Pneumonia Infection' [patent_app_type] => utility [patent_app_number] => 13/063313 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18656 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305682.pdf [firstpage_image] =>[orig_patent_app_number] => 13063313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464367 [patent_doc_number] => 20090324567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Leukocyte Cell Banks' [patent_app_type] => utility [patent_app_number] => 12/556430 [patent_app_country] => US [patent_app_date] => 2009-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10082 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324567.pdf [firstpage_image] =>[orig_patent_app_number] => 12556430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189830 [patent_doc_number] => 20110172171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION OF BRAIN OEDEMA' [patent_app_type] => utility [patent_app_number] => 13/063552 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3941 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172171.pdf [firstpage_image] =>[orig_patent_app_number] => 13063552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689451 [patent_doc_number] => 08388975 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Cancer antigen peptides derived from WT1' [patent_app_type] => utility [patent_app_number] => 12/554151 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 12490 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12554151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6294974 [patent_doc_number] => 20100160175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds' [patent_app_type] => utility [patent_app_number] => 12/583818 [patent_app_country] => US [patent_app_date] => 2009-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14186 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160175.pdf [firstpage_image] =>[orig_patent_app_number] => 12583818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8738477 [patent_doc_number] => 08410247 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'Water-soluble phosphinothiol reagents' [patent_app_type] => utility [patent_app_number] => 12/546249 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25171 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12546249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063121 [patent_doc_number] => 20110245460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'SOLVENT RESISTANT DIAFILTRATION OF PEPTIDES, PNA OR OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/058002 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7907 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245460.pdf [firstpage_image] =>[orig_patent_app_number] => 13058002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10838193 [patent_doc_number] => 08865868 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Conjugated proteins with prolonged in vivo efficacy' [patent_app_type] => utility [patent_app_number] => 13/055871 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26411 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13055871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6248771 [patent_doc_number] => 20100137223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/536688 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 16415 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137223.pdf [firstpage_image] =>[orig_patent_app_number] => 12536688 [rel_patent_id] =>[rel_patent_doc_number] =>)